BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2017
View Archived Issues
Promius Pharma's phase II study of intranasal sumatriptan meets primary endpoint
Read More
Biomarkers predict success of Tessa Therapeutics CTL immunotherapy in nasopharyngeal cancer
Read More
Subcutaneous Orencia available for patients 2 years of age and older
Read More
Genentech returning rights to GDC-0919 to NewLink Genetics
Read More
Cascadian Therapeutics' tucatinib receives FDA orphan drug designation
Read More
FDA grants fast track status to Aeolus Pharmaceuticals' AEOL-10150
Read More
Meiji Seika Pharma's TS-3112 shows promise against antibiotic-resistant bacteria
Read More
Valeant enters agreement to sell iNova Pharmaceuticals
Read More
2X Oncology obtains IND application for 2X-111 from 2-BBB Medicines
Read More
Upadacitinib meets all primary and secondary endpoints in phase III SELECT-NEXT study
Read More
TSRI and ShangPharma Innovation enter translational research collaboration
Read More
Chitinase inhibitor OAT-889 effective in models of airway inflammation
Read More
FDA grants orphan drug status to tavokinogene telsaplasmid in unresectable metastatic melanoma
Read More
FDA requests removal of Opana ER from the market
Read More
Inovio Pharmaceuticals initiates REVEAL phase III program for VGX-3100
Read More
Iproteos discovers novel matrix metalloproteinase-2/9 inhibitors
Read More
Merck & Co. describes new oxysterols receptor LXR-beta agonists
Read More
Sensorion announces positive phase I results for SENS-401
Read More
Vitros NephroCheck test becomes available in Europe
Read More
Lilly and KeyBioscience enter strategic collaboration
Read More
Wakunaga Pharmaceutical's WFQ-228 and WFQ-253 show promise for hospital-acquired pneumonia
Read More
Burtomab granted breakthrough therapy designation for advanced form of pediatric neuroblastoma
Read More
Kissei gains exclusive rights to develop and commercialize avacopan in Japan
Read More
Eureka Therapeutics and City of Hope enter agreement for phase I clinical testing of ET1402L1 CAR-T
Read More